- Home
- HQI vs SGMO Comparison
HQI vs SGMO Comparison
Compare HQI & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HQI
- SGMO
- Stock Information
- Founded
- HQI 2002
- SGMO 1995
- Country
- HQI United States
- SGMO United States
- Employees
- HQI N/A
- SGMO N/A
- Industry
- HQI Professional Services
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HQI Consumer Discretionary
- SGMO Health Care
- Exchange
- HQI Nasdaq
- SGMO Nasdaq
- Market Cap
- HQI 128.5M
- SGMO 142.5M
- IPO Year
- HQI N/A
- SGMO 2000
- Fundamental
- Price
- HQI $8.62
- SGMO $0.46
- Analyst Decision
- HQI Buy
- SGMO Buy
- Analyst Count
- HQI 1
- SGMO 7
- Target Price
- HQI $13.00
- SGMO $4.71
- AVG Volume (30 Days)
- HQI 10.5K
- SGMO 8.1M
- Earning Date
- HQI 11-06-2025
- SGMO 11-06-2025
- Dividend Yield
- HQI 2.78%
- SGMO N/A
- EPS Growth
- HQI 412.84
- SGMO N/A
- EPS
- HQI 0.50
- SGMO N/A
- Revenue
- HQI $31,691,000.00
- SGMO $32,875,000.00
- Revenue This Year
- HQI N/A
- SGMO $28.47
- Revenue Next Year
- HQI $1.38
- SGMO N/A
- P/E Ratio
- HQI $17.29
- SGMO N/A
- Revenue Growth
- HQI N/A
- SGMO N/A
- 52 Week Low
- HQI $7.75
- SGMO $0.38
- 52 Week High
- HQI $15.75
- SGMO $2.84
- Technical
- Relative Strength Index (RSI)
- HQI 49.53
- SGMO 43.21
- Support Level
- HQI $8.30
- SGMO $0.38
- Resistance Level
- HQI $9.21
- SGMO $0.56
- Average True Range (ATR)
- HQI 0.55
- SGMO 0.05
- MACD
- HQI -0.04
- SGMO 0.00
- Stochastic Oscillator
- HQI 40.29
- SGMO 42.11
About HQI HireQuest Inc. (DE)
HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The company's primary source of revenue is royalty fees based on the operation of its franchised offices.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.